These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7993719)

  • 1. Plasma substitute may improve calcium levels, clot formation.
    Oncology (Williston Park); 1994 Sep; 8(9):110. PubMed ID: 7993719
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in the blood coagulation system under the effect of BK-8 protein blood substitute].
    Riabyĭ PA
    Vrach Delo; 1969 Nov; 11():91-3. PubMed ID: 5384432
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of blood transfusion and BK-8 plasma substitute on blood coagulation in pulmonary tuberculosis].
    Morozov AF
    Probl Tuberk; 1971; 49(4):50-4. PubMed ID: 5138425
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-pharmacological approaches to decrease surgical blood loss.
    Ozier Y; Lentschener C
    Can J Anaesth; 2003; 50(6 Suppl):S19-25. PubMed ID: 14629049
    [No Abstract]   [Full Text] [Related]  

  • 5. Alternatives to allogeneic blood transfusions.
    Mulier M
    Acta Anaesthesiol Belg; 2002; 53(2):119-24. PubMed ID: 12146099
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of the protein blood substitute BK-8 on liver function and blood coagulation in certain surgical diseases in children].
    Bilich GL; Tishchenko AL; Tostanovskaia AI
    Pediatriia; 1966 Jun; 45(6):73-4. PubMed ID: 5986618
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparing the effects of colloids on clot formation.
    Kozek-Langenecker S; Scharbert G
    Anaesthesia; 2008 Jun; 63(6):673-4; author reply 674. PubMed ID: 18477285
    [No Abstract]   [Full Text] [Related]  

  • 8. Hydroxyethyl starch 130/0.4 and surgical blood loss.
    Hartog C; Brunkhorst F; Reinhart K
    Anesth Analg; 2009 Feb; 108(2):672; author reply 672-3. PubMed ID: 19151311
    [No Abstract]   [Full Text] [Related]  

  • 9. Factor XIII substitution in surgical cancer patients at high risk for intraoperative bleeding.
    Korte WC; Szadkowski C; Gähler A; Gabi K; Kownacki E; Eder M; Degiacomi P; Zoller N; Devay J; Lange J; Schnider T
    Anesthesiology; 2009 Feb; 110(2):239-45. PubMed ID: 19194150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin generation and clot formation in methylene blue-treated plasma and cryoprecipitate.
    Cardigan R; Philpot K; Cookson P; Luddington R
    Transfusion; 2009 Apr; 49(4):696-703. PubMed ID: 19170989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limitations of in vitro experiments on hydroxyethyl starch solutions.
    Scharbert G; Kozek-Langenecker S
    Anesth Analg; 2007 Sep; 105(3):885; author reply 885-6. PubMed ID: 17717268
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of plasma dilution on tissue-factor-induced thrombin generation and thromboelastography: partly compensating role of platelets.
    Schols SE; Feijge MA; Lancé MD; Hamulyák K; ten Cate H; Heemskerk JW; van Pampus EC
    Transfusion; 2008 Nov; 48(11):2384-94. PubMed ID: 18673348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clot formation and gelatin-based plasma substitutes.
    Ruttmann TG; James MF; Viljoen JF
    Lancet; 1996 Nov; 348(9036):1249-50. PubMed ID: 8898067
    [No Abstract]   [Full Text] [Related]  

  • 14. [Enhancement of coagulation caused by transfusion of artificial plasma-replacement solutions].
    Sinauridze EI; Bulanov AIu; Shcherbakova OV; Gorbatenko AS; Ataullakhanov FI
    Ter Arkh; 2009; 81(1):52-6. PubMed ID: 19253712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial.
    Schramko AA; Suojaranta-Ylinen RT; Kuitunen AH; Kukkonen SI; Niemi TT
    Anesth Analg; 2009 Jan; 108(1):30-6. PubMed ID: 19095827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clot formation and gelatin-based plasma substitutes.
    Baddeley DT; Saunders FM; Ollerenshaw L; Edwards CM
    Lancet; 1996 Jun; 347(9017):1763. PubMed ID: 8656920
    [No Abstract]   [Full Text] [Related]  

  • 17. Hydroxyethyl starch: pharmaceutical and clinical profile.
    Boldt J
    Minerva Anestesiol; 1999 May; 65(5):305-9. PubMed ID: 10389408
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of albumin 5% and artificial colloids on clot formation in small infants.
    Haas T; Preinreich A; Oswald E; Pajk W; Berger J; Kuehbacher G; Innerhofer P
    Anaesthesia; 2007 Oct; 62(10):1000-7. PubMed ID: 17845651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influencing hemostasis in substitute solution treatment].
    Máca J; Kula R; Chýlek V
    Vnitr Lek; 2009 Jan; 55(1):27-36. PubMed ID: 19227953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fresh frozen plasma does not reduce in vivo thrombin formation after neonatal cardiopulmonary bypass surgery.
    Långström S; Rautiainen P; Mildh L; Peltola K; Wartiovaara-Kautto U; Heikinheimo M; Petäjä J
    Thromb Haemost; 2008 Dec; 100(6):1207-8. PubMed ID: 19132253
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.